Addressing Financial and Social Needs Among Patients With Cancer
Public ClinicalTrials.gov record NCT06430840. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Financial hardship and health-related social needs (e.g., insecurity about food, housing, transportation, utilities) are common among patients with cancer, resulting in health disparities in cancer outcomes. Our study will test the efficacy of a multicomponent financial navigation and counseling program delivered by a financial navigator (CostCOM), vs. direct patient access to financial education materials and comprehensive list of local resources in the absence of a financial navigator (FinEd) vs. practice usual care among newly diagnosed cancer patients who screen positive for financial hardship and social needs. Investigators anticipate that both CostCOM and FinEd compared to enhanced usual care will improve cost-related cancer care nonadherence, financial worry, health insurance literacy, quality of life and sleep quality and decrease number of missed appointments.
Study identification
- NCT ID
- NCT06430840
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Interventions
- CostCOM (Cost Communication, Financial navigation and counseling) Behavioral
- Provision of local and national resources to address financial and social needs Behavioral
- Financial Education Behavioral
- Usual care Other
- Screening for financial and social needs Other
Behavioral · Other
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 25, 2024
- Primary completion
- Feb 17, 2026
- Completion
- Nov 30, 2026
- Last update posted
- Jun 21, 2026
2024 – 2026
United States locations
- U.S. sites
- 6
- U.S. states
- 1
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCI Health Cancer Center - Newport | Costa Mesa | California | 92627 | — |
| UCI Health Chao Family Comprehensive Cancer Center - Fountain Valley | Fountain Valley | California | 92708 | — |
| CHAO Family Comprehensive Cancer Center- Irvine | Irvine | California | 92612 | — |
| UCI Health Chao Family Comprehensive Cancer Center - Laguna Hills | Laguna Hills | California | 92653 | — |
| UCI Chao Family Comprehensive Cancer Center | Orange | California | 92868 | — |
| UCI Health - Yorba Linda | Yorba Linda | California | 92886 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06430840, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06430840 live on ClinicalTrials.gov.